Skip to main content
Have a personal or library account? Click to login
Amantadine in Absence Epilepsy Cover
Open Access
|Dec 1992

Full Article

Refractory absence epilepsy in 4 children was treated with amantadine as an add-on drug at the Tel Aviv University Sackler School of Medicine, Israel. The patients responded within 1 week and remained free of symptoms for 27-36 months without adverse effects. The dosage was 5-7 mg/kg per day given twice a day up to a maximum of 200 mg daily. [1]

COMMENT. Amantadine was initially used by Shields et al. in the treatment of 10 children with minor motor seizures refractory to medications. Myoclonic seizures and atypical absence seizures responded well. [2]

Language: English
Page range: 93 - 93
Published on: Dec 1, 1992
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 1992 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.